The 13C‐labelled putative erythromycin biosynthetic intermediates, ((2S,3S,4S,5R,6R,7R)‐3,6,7‐trihydroxy‐2,4,6‐trimethyl[1‐13C]nonan‐5‐olide and S‐2‐acetylaminoethyl (2R,3S,4S,5R,6S,7R)‐3,5,6,7‐tetrahydroxy‐2,4,6‐trimethyl[1‐13C]nonanethioate), which would be useful for the investigation of the chain elongation mechanism in erythromycin biosynthesis, were efficiently synthesized via aldol condensation of aldehyde derived from (2S,3R,4R,5R)‐tert‐butyldimethylsilyloxy‐5‐3,4‐O‐isopropylidene‐2,4‐dimethylheptanol, which was obtained in our previous work on erythromycin A synthesis, and sodium [1‐13C]propionate (after conversion to ester). Copyright © 2008 John Wiley & Sons, Ltd.